Ocugen, Inc. (OCGN)
Ocugen Market Cap : 280.88M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 280.88M |
| November 12, 2026 | 296.42M |
| November 11, 2026 | 325.87M |
| November 10, 2026 | 322.34M |
| November 09, 2026 | 329.84M |
| November 06, 2026 | 313.86M |
| November 05, 2026 | 277.04M |
| November 04, 2026 | 296.72M |
| November 03, 2026 | 252.85M |
| November 02, 2026 | 245.90M |
| October 30, 2026 | 238.25M |
| October 29, 2026 | 252.32M |
| October 28, 2026 | 263.23M |
| October 27, 2026 | 256.79M |
| October 26, 2026 | 240.18M |
| October 23, 2026 | 250.79M |
| October 22, 2026 | 267.85M |
| October 21, 2026 | 276.36M |
| October 20, 2026 | 275.47M |
| October 19, 2026 | 266.93M |
| October 16, 2026 | 264.56M |
| October 15, 2026 | 275.88M |
| October 14, 2026 | 285.20M |
| October 13, 2026 | 300.19M |
| October 12, 2026 | 321.14M |
| Date | Value |
|---|---|
| October 09, 2026 | 323.96M |
| October 08, 2026 | 331.38M |
| October 07, 2026 | 339.04M |
| October 06, 2026 | 352.61M |
| October 05, 2026 | 352.61M |
| October 02, 2026 | 345.83M |
| October 01, 2026 | 339.04M |
| September 30, 2026 | 349.22M |
| September 29, 2026 | 369.56M |
| September 28, 2026 | 349.22M |
| September 25, 2026 | 345.83M |
| September 24, 2026 | 339.04M |
| September 23, 2026 | 339.04M |
| September 22, 2026 | 352.61M |
| September 21, 2026 | 349.22M |
| September 18, 2026 | 359.39M |
| September 17, 2026 | 349.22M |
| September 16, 2026 | 338.50M |
| September 15, 2026 | 336.84M |
| September 14, 2026 | 359.39M |
| September 11, 2026 | 345.83M |
| September 10, 2026 | 347.52M |
| September 09, 2026 | 361.08M |
| September 08, 2026 | 450.93M |
| September 04, 2026 | 461.10M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 179.48M |
| Nektar Therapeutics | 1.272B |
| Heron Therapeutics, Inc. | 58.97M |
| TG Therapeutics, Inc. | 9.751B |
| Tonix Pharmaceuticals Holding Corp. | 57.64M |
Market Cap Related Metrics
| PS Ratio | 57.07 |
| Price | 0.8278 |
| Earnings Yield | -24.08% |